Global Director, External Research
ChromaDex, Inc.
Longmont, Colorado, United States
Yasmeen Nkrumah-Elie has over a decade of experience in molecular nutrition and toxicology research. She completed both her BS in Biological and Agricultural Engineering and her PhD in Pharmaceutical Sciences, specializing in Toxicology, from The Florida A&M University (FAMU). Her dissertation focused on the use of garlic organosulfide compounds to inhibit breast cancer initiation, in vitro. She received her postdoctoral training on the intersection of molecular nutrition and toxicology from Oregon State University, working under the leadership of Drs. Robyn Tanguay and Emily Ho on projects focused on dietary zinc deficiency and arsenic exposure using untargeted metabolomics. Prior to joining ChromaDex, she conducted clinical metabolomics research on asthma patients, managed an obesity research laboratory, and was paramount in initiating foodomics collaborations at the University of Colorado, Anschutz Medical Campus. Dr. Nkrumah-Elie has published research in the areas of toxicology, cancer, nutritional products, micronutrient deficiencies, asthma, and clinical metabolomics. As the Global Director of the ChromaDex External Research Program (CERP), Yasmeen and her team are helping to advance the science of NAD+ and nicotinamide riboside (NR) all over the world. CERP provides preclinical and clinical study material and technical assistance, in-kind, for researchers exploring NAD+ in health and disease. This program is a trailblazer in the dietary supplement space, and Yasmeen hopes other companies will develop similar programs to improve trust and advance scientific integrity in the industry. Dr. Nkrumah-Elie serves on the Membership, IDEAS, and Sustaining Partner committees for the American Society for Nutrition. She is also a member of the Senior Scientific Advisory Council for the Council for Responsible Nutrition and Co-Chair of the Conferences Sub-Committee for Women in Nutraceuticals (WIN).
Networking Table Talks with Industry Representatives
Monday, July 1, 2024
5:15 PM – 6:00 PM CT
Disclosure(s): ChromaDex: Employee (Ongoing); Stock Shareholder (excluding mutual funds) (Ongoing)